UK DRI at UCL was selected as the hub of the UK Dementia Research Institute in 2016 because of our strength to bring together excellent clinical and basic neuroscience research to advance understanding of neurodegeneration and identify novel targets and therapeutic approaches for dementia.
Our mission is to play a central and collaborative role in the UK DRI’s efforts to discover and deliver effective therapies. Our mission involves forging effective cross-disciplinary teams and approaches to understand pathogenic mechanisms; developing innovative therapeutic approaches; and providing a translational arm to the UK DRI to harness clinical resources, test and deliver treatments to patients.
People
See more details about our Group Leaders, Emerging Leaders, Lab Members, Professional Services Team and Affiliate Members here
Research
Research at the UK DRI at UCL covers the journey from the person living with dementia to the laboratory and back again - with improved diagnosis and potential therapies put to the test.
Follow us
News
UK trial launches to transform Alzheimer’s diagnosis with simple blood test
A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test, is now welcoming its first participants who will be recruited via memory clinics across the UK.
10 Sep 2025
Dementia is rare in midlife rugby players, but long-term risk may be increased
Two new studies of former rugby players, involving UCL researchers, found no cases of early-onset dementia but did find potential signs of increased risk of developing dementia later on.
03 Jul 2025
New clues as to why drugs are effective for Alzheimer’s disease
A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer’s therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.
23 Apr 2025